Your browser doesn't support javascript.
loading
Reduced gut microbial diversity in familial hypercholesterolemia with no effect of omega-3 polyunsaturated fatty acids intervention - a pilot trial.
Storm-Larsen, Christopher; Hande, Liv Nesse; Kummen, Martin; Thunhaug, Hilde; Vestad, Beate; Hansen, Simen Hyll; Hovland, Anders; Trøseid, Marius; Lappegård, Knut Tore; Hov, Johannes R.
Afiliação
  • Storm-Larsen C; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Hande LN; Department of Transplantation Medicine, Division of Surgery, Inflammatory diseases and Transplantation, Norwegian PSC Research Center, Oslo University Hospital, Oslo, Norway.
  • Kummen M; Division of Surgery, Inflammatory diseases and Transplantation, Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.
  • Thunhaug H; Division of Internal Medicine, Nordland Hospital, Bodø, Norway.
  • Vestad B; Faculty of Health Sciences, University of Tromsø, Tromsø, Norway.
  • Hansen SH; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Hovland A; Department of Transplantation Medicine, Division of Surgery, Inflammatory diseases and Transplantation, Norwegian PSC Research Center, Oslo University Hospital, Oslo, Norway.
  • Trøseid M; Division of Surgery, Inflammatory diseases and Transplantation, Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.
  • Lappegård KT; Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Hov JR; Division of Internal Medicine, Nordland Hospital, Bodø, Norway.
Scand J Clin Lab Invest ; 82(5): 363-370, 2022 09.
Article em En | MEDLINE | ID: mdl-35913798

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácidos Graxos Ômega-3 / Inibidores de Hidroximetilglutaril-CoA Redutases / Microbioma Gastrointestinal / Hiperlipoproteinemia Tipo II Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácidos Graxos Ômega-3 / Inibidores de Hidroximetilglutaril-CoA Redutases / Microbioma Gastrointestinal / Hiperlipoproteinemia Tipo II Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article